As of June 30, Health Canada had approved 16 biosimilars, based on 11 comparator products (3 in 2019).

On January 29, 2026, Canada's Drug Agency (CDA) published Improvements to the Drug Reimbursement Review Process, which includes a section for consultation on proposed changes to the reimbursement review process.

Last September, before the new world of legalized recreational cannabis had opened-up in Canada, we reported on the state of IP litigation in the cannabis industry.

Implementation will occur in 4 phases to take place over 4 years.

Apotex was unsuccessful in three Health Canada court challenges.

Participants can provide their feedback online until September 28, 2018 or in writing to the Council.

As previously reported, the Patented Medicine Prices Review Board (PMPRB) proposed amendments in June 2023 to its Interim Guidance ("Amended Interim Guidance")...

On March 6, 2025, the Patented Medicine Prices Review Board (PMPRB) announced that Thomas Digby stepped down from his role as Chairperson of the PMPRB.

Patented Medicine Prices Review Board's multi-stakeholder Steering Committee holds first meeting

On March 30, 2022, the Minister of Health tabled the 2020 Annual Report of the Patented Medicine Prices Review Board.

On May 12, 2026, the Patented Medicine Prices Review Board (PMPRB) released its May NEWSLetter. The NEWSletter provides updates on the implementation of the new Guidelines for PMPRB Staff, the consultation of the proposed Hearing Practice Directions, events in which the PMPRB participated, and new and upcoming NPDUIS research publications.

On January 1, 2026, the Guidelines for PMPRB Staff will come into effect. In November, the Patented Medicine Prices Review Board (PMPRB) held information sessions on...

Health Canada has instituted numerous measures to help address and combat COVID-19, from facilitating access to COVID-19 products to protecting the public from false ...

Our panel will discuss the implications of the decision on patent drafting, prosecution and litigation.

On October 17, 2020, the Government of Canada published a Statement on Implementation for the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) (the "Statement").

Today, the German government ratified the Unified Patent Court Agreement (UPCA), setting in motion significant changes to the patent system in Europe.

The success of the program has resulted in foreign patent office participation being extended.

Bill C-47, "An Act to implement certain provisions of the budget tabled in Parliament on March 28, 2023," aka "Budget Implementation Act, 2023, No. 1" is an omnibus bill that includes proposed amendments...

As previously reported, the Federal Court of Appeal (FCA) dismissed Pfizer's appeal from a decision granting Pharmascience's motion for a summary trial on Pfizer's defence of ex turpi causa...

In a press release yesterday, the Québec Government announced that the proposed amendments to the Regulations under the Charter of the French Language will come into force on November 24, 2016.